百邦科技(300736.SZ):與蘋果公司續簽蘋果獨立維修提供商協議
格隆匯3月31日丨百邦科技(300736.SZ)公佈,公司全資子公司上海閃電蜂電子商務有限公司(“上海閃電蜂”)於2021年4月14日與蘋果電腦貿易(上海)有限公司(“蘋果公司”)簽署了《蘋果獨立維修提供商協議》,公司在指定媒體發佈了《關於子公司簽訂重大合同暨公司爲子公司提供擔保的公告》(公告號:2021-029)。近日,上海閃電蜂與蘋果公司簽署補充協議,續簽了《蘋果獨立維修提供商協議》。
《蘋果獨立維修提供商協議》合同原期限至2022年4月30日到期,經雙方協商一致,同意合同期限延長至2022年7月31日。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.